BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27776475)

  • 1. Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy.
    Girotti AW; Fahey JM; Korytowski W
    Curr Med Chem; 2016; 23(24):2754-2769. PubMed ID: 27776475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
    Fahey JM; Girotti AW
    Nitric Oxide; 2017 Jan; 62():52-61. PubMed ID: 28007662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.
    Fahey JM; Girotti AW
    Nitric Oxide; 2015 Sep; 49():47-55. PubMed ID: 26068242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells.
    Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
    Free Radic Biol Med; 2017 Jan; 102():111-121. PubMed ID: 27884704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-Tumor Activity of Endogenous Nitric Oxide in Anti-Tumor Photodynamic Therapy: Recently Recognized Bystander Effects.
    Girotti AW; Bazak J; Korytowski W
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress.
    Bhowmick R; Girotti AW
    Free Radic Biol Med; 2013 Apr; 57():39-48. PubMed ID: 23261943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy.
    Girotti AW
    Lasers Surg Med; 2018 Jul; 50(5):590-598. PubMed ID: 29504635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric Oxide-Mediated Resistance to Antitumor Photodynamic Therapy.
    Girotti AW
    Photochem Photobiol; 2020 May; 96(3):500-505. PubMed ID: 31545517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling events in apoptotic photokilling of 5-aminolevulinic acid-treated tumor cells: inhibitory effects of nitric oxide.
    Bhowmick R; Girotti AW
    Free Radic Biol Med; 2009 Sep; 47(6):731-40. PubMed ID: 19524035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of iNOS/NO in Cancer Cells That Survive a Photodynamic Challenge: Role of No in Accelerated Cell Migration and Invasion.
    Girotti AW; Korytowski W
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy.
    Bhowmick R; Girotti AW
    Free Radic Biol Med; 2010 May; 48(10):1296-301. PubMed ID: 20138143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Endogenous Nitric Oxide in Hyperaggressiveness of Tumor Cells that Survive a Photodynamic Therapy Challenge.
    Girotti AW
    Crit Rev Oncog; 2016; 21(5-6):353-363. PubMed ID: 29431083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nitric oxide in the treatment of tumours with aminolaevulinic acid-induced photodynamic therapy.
    Reeves KJ; Reed MW; Brown NJ
    J Photochem Photobiol B; 2010 Dec; 101(3):224-32. PubMed ID: 20724176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
    Fahey JM; Stancill JS; Smith BC; Girotti AW
    J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model.
    Fahey JM; Emmer JV; Korytowski W; Hogg N; Girotti AW
    Photochem Photobiol; 2016 Nov; 92(6):842-853. PubMed ID: 27608331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-generated nitric oxide as an antagonist of photodynamic therapy.
    Girotti AW
    Photochem Photobiol Sci; 2015 Aug; 14(8):1425-32. PubMed ID: 25706541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid upregulation of cytoprotective nitric oxide in breast tumor cells subjected to a photodynamic therapy-like oxidative challenge.
    Bhowmick R; Girotti AW
    Photochem Photobiol; 2011; 87(2):378-86. PubMed ID: 21143607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-elicited resistance to anti-glioblastoma photodynamic therapy.
    Girotti AW; Fahey JM; Korytowski W
    Cancer Drug Resist; 2020 3rd Quarter; 3(3):401-414. PubMed ID: 33073206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nitric oxide in delta-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells.
    Yamamoto F; Ohgari Y; Yamaki N; Kitajima S; Shimokawa O; Matsui H; Taketani S
    Biochem Biophys Res Commun; 2007 Feb; 353(3):541-6. PubMed ID: 17196160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.